Furthermore, cancer cells produce several growth factors, such as PDGF-B, VEGFA, and TGF-β1, which may trigger the prevalence of a PDGFR+/desmin+ pericyte phenotype and not the PDGFR+/CD13+ phenotype. This evidence concerns the gene DES and cancer.